PYRROLOBENZODIAZEPINKONJUGATE

European patent · EP3525830 · In force

Register entry

Publication number
EP3525830
Application number
EP17791980
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 13, 2017
Published
Aug 21, 2019
Granted
Mar 10, 2021
Protection ends at the latest
Oct 12, 2037
Next annual fee due
Oct 31, 2026
IPC classes
A61K 47/68 (2017.01)
C07H 15/203 (2006.01)
A61P 35/00 (2006.01)
A61P 43/00 (2006.01)
Priority
GB 201617466 14.10.2016
PCT application
PCT/EP2017/076162 13.10.2017
PCT publication
WO2018/069490 19.04.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Jan 30, 2025

    Change

    Published in Swissreg on 30.01.2025

  3. Nov 1, 2023

    Change

    Published in Swissreg on 01.11.2023

  4. Nov 1, 2022

    Change

    Published in Swissreg on 01.11.2022

  5. Jan 19, 2022

    Change

    Published in Swissreg on 19.01.2022

  6. Mar 10, 2021

    Granted

    Published in Swissreg on 10.03.2021

Parties

Holder

Medimmune Limited

Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH, GB

Inventor

GREGSON, Stephen John

Cambridge Cambridgeshire CB21 6GH, GB

HOWARD, Philip Wilson

Cambridge Cambridgeshire CB21 6GH, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.